The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's ...

For more than a decade, Carnegie Mellon neuroscientist Aryn Gittis has been unraveling the mystery of how the brain controls movement — research now pointing toward new treatments for Parkinson’s ...

Precision medicine holds enormous promise in enhancing treatment efficacy and advancing therapeutic development, leading to more equitable care. However, to realise this promise in all individuals ...

Previous applications of TUS were limited, as they were imprecise and too weak to target areas deeper in the brain. Parkinson ...

The FDA's "breakthrough" designation for CND Life Sciences' diagnostic tool could open new doors for the Arizona firm as it ...

Researchers have designed a peptide that stabilizes a key brain protein linked to Parkinson’s. Scientists from the University of Bath, working with colleagues at the Universities of Oxford and Bristol ...

Scientists discover that gut bacteria and B vitamins may influence Parkinson's disease, offering a potentially safe ...

L-R: Nishi Singh, Kimberley Gillman and Dr Anita Goff have recruited local patients in Somerset for the trial [Somerset NHS Foundation Trust] Researchers in Somerset are joining others across the UK ...

Parkinson’s disease can be difficult to diagnose, but one common symptom of the progressive neurodegenerative condition is small, frequent tremors in the hands. Now, with an eye towards screening and ...

How can AI help identify early symptoms of Parkinson’s disease (PD)? This is what a recent study published in npj Parkinson’s Disease hopes to address as a team of researchers investigated using an AI ...

The toxins could potentially be used as ‘markers’ for doctors to identify Parkinson’s patients at a higher risk of developing ...